Table 1.
DNA and RNA sequences used in this work.
| DNA oligonucleotide sequences | |
| 5a | 5’ Cy3-TAGTGTTGACGAAGGGAC-C3SSC3 3’ |
| 5b | 5’ TAGTGTTGACGAAGGGAC-XT-C6-NH2 3’ |
| 5c | 5’ TAGTGTTGACGAAGGGAC-XT-C6-VT680 3’ |
| 6a | 5’ GTCCCTTCGTCAACACTA-XT-C6-NH2 3’ |
| 6b | 5’ GTCCCTTCGTCAACACTA-XT-C6-VT750 3’ |
| RNA oligonucleotide sequences | |
| 7 | 5’ GUCCCUUCGUCAACACUA-C6-NH2 3’ |
| 8a | 5’ UAGUGUUGACGAAGGGAC-C6-NH2 3’ |
| 8b | 5’ UAGUGUUGACGAAGGGAC-C6-VT680 3’ |
| 9 | 5’ Cy3-AAAAAAAAAAAAAAAAAA 3’ |
| 10 | 5’ UUUUUUUUUUUUUUUUUU-C6-NH2 3’ |
| Additional substituents in the oligonucleotide sequences above were abbreviated as follows: C6 indicated a (-CH2-)6 hexyl spacer; C3 a (-CH2-)3 propyl spacer; X a hexaethylene glycol spacer; and C3SSC3 a terminal (-CH2-)3-SS-(-CH2-)2-CH3 group. | |